It is really difficult to publish translational manuscripts these days, but this is a prime example of a good collaboration between pharmaceutical and environmental sciences. As pharmaceutical scientists, we sometimes have to use a certain material to facilitate drug therapy. But if we have a choice and more than one coating or one polymer actually works, why not choose the one which is best for the environment? This study helps you sort that out.
A wide variety of models have been established to predict the performance of nanomedicines for the peroral route of administration, but only a handful for injectables. Liposomal temoporfin has been evaluated in a phase I clinical trial. This investigation was focused on the prediction of the performance of liposomes in humans using preclinical in vitro and in vivo data. Congratulations to our young researcher Laura Jablonka who is responsible for this great accomplishment. Also, it is a prime example for international collaborations by involving researchers from Germany and Singapore…
I am pleased to be an invited speaker at the CRS conference in Mumbai in February 2020. I will talk about our work on in vitro-in vivo correlation for nanodelivery systems. For more information check out the conference brochure.
